Items where authors include "Chantry, A."
Article
Fan, R. orcid.org/0000-0003-1032-4546, Satilmis, H., Vandewalle, N. et al. (16 more authors) (2023) Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma. Journal for ImmunoTherapy of Cancer, 11 (1). e005319. ISSN 2051-1426
Rubins, Z., Gibson, B.J. and Chantry, A. (2022) What can patient narratives reveal to us about the experience of a diagnosis of myeloma? A qualitative scoping review. Journal of Patient Experience, 9. ISSN 2374-3735
Stewart, G., Chantry, A. and Lawson, M. orcid.org/0000-0002-5446-923X (2021) The use of oncolytic viruses in the treatment of multiple myeloma. Cancers, 13 (22). 5687.
Scott, S., Cartwright, A., Francis, S. et al. (23 more authors) (2021) Assessment of droplet digital polymerase chain reaction for measuring BCR-ABL1 in chronic myeloid leukaemia in an international interlaboratory study. British Journal of Haematology, 194 (1). pp. 53-60. ISSN 0007-1048
Zhang, D., De Veirman, K., Fan, R. et al. (15 more authors) (2020) ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation. Stem Cell Research & Therapy, 11 (1). 516.